List of Excipients in API sunitinib malate
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing sunitinib malate
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | SUTENT | sunitinib malate | 0069-0550 | CROSCARMELLOSE SODIUM | |
| Pfizer Laboratories Div Pfizer Inc | SUTENT | sunitinib malate | 0069-0550 | FERRIC OXIDE RED | |
| Pfizer Laboratories Div Pfizer Inc | SUTENT | sunitinib malate | 0069-0550 | GELATIN | |
| Pfizer Laboratories Div Pfizer Inc | SUTENT | sunitinib malate | 0069-0550 | MAGNESIUM STEARATE | |
| Pfizer Laboratories Div Pfizer Inc | SUTENT | sunitinib malate | 0069-0550 | MANNITOL | |
| Pfizer Laboratories Div Pfizer Inc | SUTENT | sunitinib malate | 0069-0550 | POTASSIUM HYDROXIDE | |
| Pfizer Laboratories Div Pfizer Inc | SUTENT | sunitinib malate | 0069-0550 | POVIDONE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing sunitinib malate
Detailed excipient profiles for sunitinib malate
Excipient focus: AMMONIA
sunitinib malate drug variants containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | sunitinib malate | 0378-6678 |
| >Company | >Ingredient | >NDC |
sunitinib malate drug variants not containing AMMONIA
Excipient focus: BUTYL ALCOHOL
sunitinib malate drug variants containing BUTYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| DrReddys Laboratories Inc | sunitinib malate | 43598-045 |
| >Company | >Ingredient | >NDC |
sunitinib malate drug variants not containing BUTYL ALCOHOL
Excipient focus: CROSCARMELLOSE SODIUM
sunitinib malate drug variants containing CROSCARMELLOSE SODIUM
sunitinib malate drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: D&C RED NO. 28
sunitinib malate drug variants containing D&C RED NO. 28
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | sunitinib malate | 0093-8199 |
| AvKARE | sunitinib malate | 42291-901 |
| >Company | >Ingredient | >NDC |
sunitinib malate drug variants not containing D&C RED NO. 28
Excipient focus: D&C YELLOW NO. 10 ALUMINUM LAKE
sunitinib malate drug variants containing D&C YELLOW NO. 10 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | sunitinib malate | 0093-8199 |
| AvKARE | sunitinib malate | 42291-901 |
| >Company | >Ingredient | >NDC |
sunitinib malate drug variants not containing D&C YELLOW NO. 10 ALUMINUM LAKE
Excipient focus: FD&C BLUE NO. 1
sunitinib malate drug variants containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | sunitinib malate | 0093-8199 |
| AvKARE | sunitinib malate | 42291-901 |
| >Company | >Ingredient | >NDC |
sunitinib malate drug variants not containing FD&C BLUE NO. 1
Excipient focus: FD&C BLUE NO. 1 ALUMINUM LAKE
sunitinib malate drug variants containing FD&C BLUE NO. 1 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | sunitinib malate | 0093-8199 |
| AvKARE | sunitinib malate | 42291-901 |
| >Company | >Ingredient | >NDC |
sunitinib malate drug variants not containing FD&C BLUE NO. 1 ALUMINUM LAKE
Excipient focus: FD&C BLUE NO. 2--ALUMINUM LAKE
sunitinib malate drug variants containing FD&C BLUE NO. 2--ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | sunitinib malate | 0093-8199 |
| AvKARE | sunitinib malate | 42291-901 |
| >Company | >Ingredient | >NDC |
sunitinib malate drug variants not containing FD&C BLUE NO. 2--ALUMINUM LAKE
Excipient focus: FD&C RED NO. 40
sunitinib malate drug variants containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | sunitinib malate | 0093-8199 |
| AvKARE | sunitinib malate | 42291-901 |
| >Company | >Ingredient | >NDC |
sunitinib malate drug variants not containing FD&C RED NO. 40
Excipient focus: FERRIC OXIDE RED
sunitinib malate drug variants containing FERRIC OXIDE RED
sunitinib malate drug variants not containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | sunitinib malate | 0093-8199 |
| AvKARE | sunitinib malate | 42291-901 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
sunitinib malate drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| DrReddys Laboratories Inc | sunitinib malate | 43598-045 |
| US Pharmaceuticals | sunitinib malate | 63539-019 |
| >Company | >Ingredient | >NDC |
sunitinib malate drug variants not containing FERRIC OXIDE YELLOW
Excipient focus: FERROSOFERRIC OXIDE
sunitinib malate drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | sunitinib malate | 0093-8199 |
| Mylan Pharmaceuticals Inc | sunitinib malate | 0378-6678 |
| AvKARE | sunitinib malate | 42291-901 |
| DrReddys Laboratories Inc | sunitinib malate | 43598-045 |
| US Pharmaceuticals | sunitinib malate | 63539-019 |
| >Company | >Ingredient | >NDC |
sunitinib malate drug variants not containing FERROSOFERRIC OXIDE
Excipient focus: GELATIN
sunitinib malate drug variants containing GELATIN
sunitinib malate drug variants not containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: ISOPROPYL ALCOHOL
sunitinib malate drug variants containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| DrReddys Laboratories Inc | sunitinib malate | 43598-045 |
| >Company | >Ingredient | >NDC |
sunitinib malate drug variants not containing ISOPROPYL ALCOHOL
Excipient focus: MAGNESIUM STEARATE
sunitinib malate drug variants containing MAGNESIUM STEARATE
sunitinib malate drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
sunitinib malate drug variants containing MANNITOL
sunitinib malate drug variants not containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POTASSIUM HYDROXIDE
sunitinib malate drug variants containing POTASSIUM HYDROXIDE
sunitinib malate drug variants not containing POTASSIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | sunitinib malate | 0093-8199 |
| Mylan Pharmaceuticals Inc | sunitinib malate | 0378-6678 |
| AvKARE | sunitinib malate | 42291-901 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
sunitinib malate drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | sunitinib malate | 0069-0550 |
| DrReddys Laboratories Inc | sunitinib malate | 43598-045 |
| US Pharmaceuticals | sunitinib malate | 63539-019 |
| Novugen Pharma (USA) LLC | sunitinib malate | 82293-014 |
| >Company | >Ingredient | >NDC |
sunitinib malate drug variants not containing POVIDONE
Excipient focus: POVIDONE K25
sunitinib malate drug variants containing POVIDONE K25
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | sunitinib malate | 0069-0550 |
| DrReddys Laboratories Inc | sunitinib malate | 43598-045 |
| Aurobindo Pharma Limited | sunitinib malate | 59651-464 |
| US Pharmaceuticals | sunitinib malate | 63539-019 |
| >Company | >Ingredient | >NDC |
sunitinib malate drug variants not containing POVIDONE K25
Excipient focus: POVIDONE K30
sunitinib malate drug variants containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | sunitinib malate | 0093-8199 |
| NorthStar RxLLC | sunitinib malate | 16714-676 |
| AvKARE | sunitinib malate | 42291-901 |
| Sun Pharmaceutical Industries Inc | sunitinib malate | 63304-091 |
| >Company | >Ingredient | >NDC |
sunitinib malate drug variants not containing POVIDONE K30
Excipient focus: PROPYLENE GLYCOL
sunitinib malate drug variants containing PROPYLENE GLYCOL
sunitinib malate drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| NorthStar RxLLC | sunitinib malate | 16714-676 |
| Sun Pharmaceutical Industries Inc | sunitinib malate | 63304-091 |
| >Company | >Ingredient | >NDC |
Excipient focus: SHELLAC
sunitinib malate drug variants containing SHELLAC
sunitinib malate drug variants not containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
sunitinib malate drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | sunitinib malate | 0378-6678 |
| >Company | >Ingredient | >NDC |
sunitinib malate drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM HYDROXIDE
sunitinib malate drug variants containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | sunitinib malate | 0069-0550 |
| US Pharmaceuticals | sunitinib malate | 63539-019 |
| >Company | >Ingredient | >NDC |
sunitinib malate drug variants not containing SODIUM HYDROXIDE
Excipient focus: SODIUM LAURYL SULFATE
sunitinib malate drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | sunitinib malate | 0378-6678 |
| DrReddys Laboratories Inc | sunitinib malate | 43598-045 |
| >Company | >Ingredient | >NDC |
sunitinib malate drug variants not containing SODIUM LAURYL SULFATE
Excipient focus: TITANIUM DIOXIDE
sunitinib malate drug variants containing TITANIUM DIOXIDE
sunitinib malate drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
